Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery

摘要: Purpose To assess the risk for intraoperative and postoperative bleeding associated with antiplatelet and/or anticoagulant treatment in patients having uneventful phacoemulsification. Setting Kokura Memorial Hospital, Kitakyusyu, Japan. Methods In a nonrandomized case series, consecutive had phacoemulsification intraocular lens implantation under sub-Tenon anesthesia. All were on warfarin, acetylsalicylic acid (aspirin) therapy, or both. Patients discontinued therapy 1 week before surgery (discontinuation group) continued therapeutic regimen until time of (maintenance group). Results The discontinuation group comprised 182 maintenance group, 173 patients. There was no significant difference between 2 groups mean prothrombin time–international normalized ratio taking warfarin ( P = .6). Although there any case, 47 eyes (16.5%) 31 (10.8%) subconjunctival hemorrhage postoperatively .0309). Minor ocular occurred 11 (4.0%) 7 (2.5%) .4). During 1-month period, change corrected distance visual acuity −0.462 logMAR ± 0.331 (SD) −0.434 0.318 .3). Conclusions aspirin, both up to significantly higher incidence than those who therapy. complications improvement. Financial Disclosure author has financial proprietary interest material method mentioned.